23 Hrs
Source:
Financial Times
Financial Times
Ready to play
Ready to play
A new pill developed by a drugmaker aims to compete with leading diabetes medication companies Novo Nordisk and Eli Lilly, potentially impacting the market for diabetes treatments.
Notice: This Is an AI-Generated Summary
Comments (0)